Israeli researchers use novel methods to seek treatments for deadly pancreatic cancer
Aviad Weissman
Dr. Oren Parnas of Jerusalem s Hebrew University is profiling individual pancreatic cancer cells from early stage tumors in a bid to discover markers for early diagnosis.
By the time Barbara Goodman was diagnosed with Stage IV pancreatic cancer in October 2001, there were already 30 tumors in her liver. We knew we were in for a pretty tough battle, recalled her husband, Kenneth Goodman, then president of New York-based Forest Laboratories, a pharmaceutical company. But I had an entire research organization I could draw upon.
Nevertheless, nine months after her diagnosis, Barbara died. She was only 51, far younger than usual for pancreatic cancer patients, who are diagnosed, on average, at 70.
Israeli researchers use novel methods to seek treatments for deadly pancreatic cancer jewishledger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishledger.com Daily Mail and Mail on Sunday newspapers.
In his wife’s memory, Kenneth Goodman established the Barbara S. Goodman Endowed Research Career Development Award for Pancreatic Cancer at the Israel Cancer Research Fund, which supports scientific research in Israel with funds raised in North America.
Israeli researchers use novel methods to seek treatments for deadly pancreatic cancer January 11, 2021 2:03 pm Dr. Ziv Gil of the Technion and Rambam hospital in Haifa, is researching the cellular mechanisms underlying the spread, or metastasis, of pancreatic cancer cells. (Pioter Flite)
Advertisement
By the time Barbara Goodman was diagnosed with Stage IV pancreatic cancer in October 2001, there were already 30 tumors in her liver.
“We knew we were in for a pretty tough battle,” recalled her husband, Kenneth Goodman, then president of New York-based Forest Laboratories, a pharmaceutical company. “But I had an entire research organization I could draw upon.”
Nevertheless, nine months after her diagnosis, Barbara died. She was only 51, far younger than usual for pancreatic cancer patients, who are diagnosed, on average, at 70.